AtaiBeckley Inc. (ATAI)
NASDAQ: ATAI · Real-Time Price · USD
7.24
-0.02 (-0.28%)
At close: Aug 17, 2026, 4:00 PM EDT
7.24
0.00 (0.00%)
Pre-market: Aug 18, 2026, 7:58 AM EDT
AtaiBeckley Employees
AtaiBeckley had 99 employees as of December 31, 2025. The number of employees increased by 45 or 83.33% compared to the previous year.
Employees
99
Change (1Y)
45
Growth (1Y)
83.33%
Revenue / Employee
$45,172
Profits / Employee
-$6,749,424
Market Cap
2.69B
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 99 | 45 | 83.33% |
| Dec 31, 2024 | 54 | -29 | -34.94% |
| Dec 31, 2023 | 83 | -50 | -37.59% |
| Dec 31, 2022 | 133 | 46 | 52.87% |
| Dec 31, 2021 | 87 | 52 | 148.57% |
| Mar 31, 2021 | 35 | - | - |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Zai Lab | 1,784 |
| Ultragenyx Pharmaceutical | 1,371 |
| Beam Therapeutics | 540 |
| Nurix Therapeutics | 317 |
| Viridian Therapeutics | 252 |
| Pharvaris | 148 |
| Kodiak Sciences | 141 |
| Nektar Therapeutics | 63 |
ATAI News
- 19 hours ago - AtaiBeckley downgraded to Perform from Outperform at Oppenheimer - TheFly
- 1 day ago - AtaiBeckley downgraded to Hold from Buy at Deutsche Bank - TheFly
- 7 days ago - AtaiBeckley Quarterly report: Q2 2026 - Filings
- 8 days ago - AtaiBeckley Proxy statement: Proxy filing - Filings
- 19 days ago - AtaiBeckley Proxy statement: Proxy filing - Filings
- 4 weeks ago - AtaiBeckley downgraded to Neutral from Buy at H.C. Wainwright - TheFly
- 4 weeks ago - AtaiBeckley downgraded to Hold from Buy at Berenberg - TheFly
- 4 weeks ago - The market for psychedelic drugs to treat mental health conditions gets a big buy signal - CNBC